[HTML][HTML] An Antibacterial Peptide with High Resistance to Trypsin Obtained by Substituting d-Amino Acids for Trypsin Cleavage Sites
X Zhao, M Zhang, I Muhammad, Q Cui, H Zhang, Y Jia… - Antibiotics, 2021 - mdpi.com
The poor stability of antibacterial peptide to protease limits its clinical application. Among
these limitations, trypsin mainly exists in digestive tract, which is an insurmountable obstacle …
these limitations, trypsin mainly exists in digestive tract, which is an insurmountable obstacle …
An antibacterial peptide with high resistance to trypsin obtained by substituting D-amino acids for trypsin cleavage sites.
X Zhao, M Zhang, I Muhammad, Q Cui, H Zhang, Y Jia… - 2021 - cabidigitallibrary.org
The poor stability of antibacterial peptide to protease limits its clinical application. Among
these limitations, trypsin mainly exists in digestive tract, which is an insurmountable obstacle …
these limitations, trypsin mainly exists in digestive tract, which is an insurmountable obstacle …
An Antibacterial Peptide with High Resistance to Trypsin Obtained by Substituting d-Amino Acids for Trypsin Cleavage Sites
X Zhao, M Zhang, I Muhammad… - Antibiotics (Basel …, 2021 - pubmed.ncbi.nlm.nih.gov
The poor stability of antibacterial peptide to protease limits its clinical application. Among
these limitations, trypsin mainly exists in digestive tract, which is an insurmountable obstacle …
these limitations, trypsin mainly exists in digestive tract, which is an insurmountable obstacle …
[HTML][HTML] An Antibacterial Peptide with High Resistance to Trypsin Obtained by Substituting d-Amino Acids for Trypsin Cleavage Sites
X Zhao, M Zhang, I Muhammad, Q Cui, H Zhang, Y Jia… - Antibiotics, 2021 - ncbi.nlm.nih.gov
The poor stability of antibacterial peptide to protease limits its clinical application. Among
these limitations, trypsin mainly exists in digestive tract, which is an insurmountable obstacle …
these limitations, trypsin mainly exists in digestive tract, which is an insurmountable obstacle …
An Antibacterial Peptide with High Resistance to Trypsin Obtained by Substituting d-Amino Acids for Trypsin Cleavage Sites.
X Zhao, M Zhang, I Muhammad, Q Cui… - Antibiotics (Basel …, 2021 - europepmc.org
The poor stability of antibacterial peptide to protease limits its clinical application. Among
these limitations, trypsin mainly exists in digestive tract, which is an insurmountable obstacle …
these limitations, trypsin mainly exists in digestive tract, which is an insurmountable obstacle …
An Antibacterial Peptide with High Resistance to Trypsin Obtained by Substituting d-Amino Acids for Trypsin Cleavage Sites
X Zhao, M Zhang, I Muhammad, Q Cui, H Zhang… - …, 2021 - search.proquest.com
The poor stability of antibacterial peptide to protease limits its clinical application. Among
these limitations, trypsin mainly exists in digestive tract, which is an insurmountable obstacle …
these limitations, trypsin mainly exists in digestive tract, which is an insurmountable obstacle …
An Antibacterial Peptide with High Resistance to Trypsin Obtained by Substituting d-Amino Acids for Trypsin Cleavage Sites.
X Zhao, M Zhang, I Muhammad, Q Cui… - Antibiotics (2079 …, 2021 - search.ebscohost.com
The poor stability of antibacterial peptide to protease limits its clinical application. Among
these limitations, trypsin mainly exists in digestive tract, which is an insurmountable obstacle …
these limitations, trypsin mainly exists in digestive tract, which is an insurmountable obstacle …